DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers

Information source: University of Southern California
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Peptic Ulcer Hemorrhage

Intervention: Proton pump inhibitor (lansoprazole) (Drug)

Phase: N/A

Status: Completed

Sponsored by: University of Southern California

Official(s) and/or principal investigator(s):
Loren Laine, M.D., Principal Investigator, Affiliation: University of Southern California

Summary

Patients with bleeding ulcers identified by endoscopy will be randomly assigned to receive an acid-blocking drug (called a proton pump inhibitor [PPI]) either by mouth every 3 hours for 24 hours or intravenously (IV) by constant infusion for 24 hours. A pH probe in the stomach will be used to determine intragastric pH (a measure of the acid production in the stomach) at baseline and during the 24 hours of therapy. The purpose of the study is to determine if the continuous intravenous administration of the drug provides better reduction of acid in the stomach than the oral administration.

Clinical Details

Official title: Prospective Randomized Comparison of the Effect of Frequent Oral Dosing Versus Constant IV Infusion of Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers

Study design: Treatment, Randomized, Open Label, Parallel Assignment, Pharmacodynamics Study

Primary outcome: Intragastric pH > 6

Secondary outcome: Mean intragastric pH

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients presenting to hospital with overt upper GI bleeding and found to have an

ulcer as the cause on endoscopy

Exclusion Criteria:

- Previous gastric surgery

- Active bleeding at end of endoscopy (despite hemostatic therapy)

- Recent PPI or H2RA use

Locations and Contacts

L.A. County + U.S.C. Medical Center, Los Angeles, California 90033, United States
Additional Information

Starting date: February 2006
Ending date: December 2007
Last updated: March 18, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009